Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

GeneXpert Performance Evaluation for Linkage to Tuberculosis Care: The XPEL-TB Trial

NCT03044158 is registered in ClinicalTrials.gov with University of California, San Francisco as lead sponsor.

NCT NCT03044158
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03044158 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
GeneXpert Performance Evaluation for Linkage to Tuberculosis Care: The XPEL-TB Trial
Lead sponsor
University of California, San Francisco
Phase
Not applicable
Overall status
Completed
Start date
October 22, 2018
Completion date
July 31, 2022
Enrollment
10,644 (actual)
Sites
20

Conditions

As the registry lists them; a condition with its own page is linked.

rifampicin resistant tuberculosis, tuberculosis, pulmonary